Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 24 | 129 | 882 | 564 | 0 |
| Cost of Goods | 137 | 70 | 250 | 212 | N/A |
| Gross Profit | -113 | 59 | 632 | 352 | N/A |
| Operating Expenses | 4,478 | 4,122 | 4,520 | 3,536 | 0 |
| Operating Income | -4,454 | -3,993 | -3,638 | -2,972 | N/A |
| Other Income | -952 | -1 | 4 | 31 | 0 |
| Pre-tax Income | -5,406 | -3,994 | -3,634 | -2,941 | 0 |
| Net Income Continuous | -5,406 | -3,994 | -3,634 | -2,941 | N/A |
| Net Income | $-5,406 | $-3,994 | $-3,634 | $-2,941 | $N/A |
| EPS Basic Total Ops | -14.69 | -10.81 | -9.84 | -8.14 | N/A |
| EPS Basic Continuous Ops | -14.69 | -10.81 | -9.84 | -8.14 | N/A |
| EPS Diluted Total Ops | -14.69 | -10.81 | -9.84 | -8.14 | N/A |
| EPS Diluted Continuous Ops | -14.69 | -10.81 | -9.84 | -8.14 | N/A |
| EBITDA(a) | $-4,362 | $-3,899 | $-3,543 | $-2,846 | $N/A |